anthracyclines
1 product
69 abstracts
Abstract
ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma.Org: Musculoskeletal Tumor Center, Peking University People's Hospital, Tianjin Medical University Cancer Institute and Hospital, Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,
Abstract
RAGE inhibition to decrease cancer therapy related cardiotoxicity in women with early breast cancer (RAGE).Org: Medstar Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Lombardi Cancer Center Georgetown University, Regional Cancer Care Associates, Cantex Pharmaceuticals, Georgetown University Medical Center,
Abstract
Personalized neoadjuvant strategy in ER positive and HER2 negative breast cancer to increase BCS rate (PLATO): A prospective, multicenter, phase II clinical trial.Org: Seoul National University Hospital, Seoul National University College of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul National University Bundang Hospital,
Abstract
A prospective study of all-trans retinoic acid plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia.Org: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Hygeia Suzhou Yongding Hospital, National Regional Medical Center,
Abstract
Unveiling the relationship between the UGT2B gene family and neoadjuvant treatment response in patients with HER2-positive breast cancer.Org: Instituto Biomedicina Sevilla, Institute of Biomedicine of Seville (IBiS), Andalusian - Roche Network Mixed Alliance in Precision Medical Oncology,
Abstract
Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities.Org: Department of Radiology - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy, Department of Radiology - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy, Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies - IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Department of Surgery – IRCCS Humanitas Research Hospital, Rozzano, Italy, Department of Cancer Medicine - Ospedale Città della Scienza e della Salute, Torino, Italy,
Abstract
Treatment (Tx) patterns, efficacy and safety of eribulin for advanced and heavily pretreated breast cancer (ABC): Updated results from a single-center, real-world study.Org: Jiaotong University,
Abstract
A prospective phase II study of neoadjuvant therapy guided by personalized drug-testing on patient-derived tumor-like cell clusters for early breast cancer.Org: College of Future Technology Peking University, Peking University People's Hospital Breast Center,
Abstract
Optimal neoadjuvant treatment and prognostic factors in patients with HR-positive/HER2-positive early or locally advanced breast cancer: A national real-world study in China.Org: Department of Breast Disease, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China,
Abstract
Trastuzumab-induced cardiotoxicity in patients with metastatic HER2-positive breast cancer treated at a reference hospital in Mexico.Org: Hospital de Oncologia Centro Medico Nacional Siglo XXI,
Abstract
Maintenance treatment with toripalimab and anlotinib after anthracycline-based chemotherapy in patients with advanced soft tissue sarcoma (TORAN): A single-arm, phase 2 trial.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, West China Hospital, Sichuan University, Chengdu Origen Biotechnology,
Abstract
Assessing the feasibility and cost-effectiveness of all oral adjuvant chemotherapy (cyclophosphamide, methotrexate, capecitabine) in high-risk hormone receptor positive breast cancer.Org: University of Illinois Hospital & Health Sciences System, University of Illinois Chicago, Stanford University School of Medicine,
Abstract
Predicting epirubicin response in Danish patients with breast cancer.Org: Aida Oncology, Dragor, Denmark, JADBio, Crete, Greece, Raven Biosciences,
Abstract
Effect of fructose on anthracycline and HER-2 blocking agent mediated cardiotoxicity through NLRP3 and MyD88 mediated pathways: New roles of sweeteners in cardio-oncology.Org: Fondazione G. Pascale, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar Di Valpolicella,
Abstract
Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on systemic H-FABP and monocyte-to-lymphocyte ratio in preclinical models of antracycline induced cardiotoxicity.Org: Division of Cardiology, Naples, Italy, Division of Cardiology, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido Di Camaiore, Italy, Servizi Cardiologici Integrati, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy, Sperimentazione Animale, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy, Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy,
Abstract
Enhancing prediction of cancer therapy-related cardiomyopathy from surveillance echocardiograms: A Children’s Oncology Group (COG) report.Org: City of Hope National Medical Center, University of Washington School of Medicine, University of Minnesota, Fred Hutchinson Cancer Center, Seattle Children's Hospital,
Abstract
Carvedilol for prevention of heart failure in anthracycline-exposed survivors of childhood cancer: Results from COG ALTE1621.Org: City of Hope National Medical Center, City of Hope Comprehensive Cancer Center, Boston Children's Hospital, Boston Children's Hospital and Dana-Farber Cancer Institute, St. Jude Children's Research Hospital,
Abstract
Deep learning with whole slides images to predict histological response to neoadjuvant chemotherapy in patients with resectable high grade soft-tissue sarcomas: A multicenter study.Org: OWKIN, Bergonié Institute, Centre Léon Bérard, Institut Bergonié,
Abstract
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.Org: Oncology Institute of Southern Switzerland, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland, University of Southampton,
Abstract
Association of intensive chemotherapy with the rate of pathogenic driver mutation clearance in acute myeloid leukemia.Org: Ochsner Clinic Foundation, University of Queensland, Ochsner Health System,
Abstract
Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.Org: Department of Experimental Oncology, Milano, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Vall d'Hebron University Hospital, Bergonié Institute,
Abstract
Neoadjuvant single-dose trilaciclib prior to combination chemotherapy in patients with early triple-negative breast cancer: Safety, efficacy, and immune correlate data from a phase 2 study.Org: Department of Medicine, Duke University School of Medicine, Texas Oncology-Baylor Charles A. Sammons Cancer Center, PIH Health Whittier Hospital, Nebraska Hematology-Oncology P.C., Division of Hematology/Oncology, David Geffen School of Medicine at the University of California Los Angeles/Jonsson Comprehensive Cancer Center,
Abstract
Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study.Org: Shanghai Cancer Center, Shanghai, China, Fudan University Shanghai Cancer Center, Department of Breast Surgery, Kyorin University School of Medicine/Saitama Medical Center, Tokyo, Japan, Key Laboratory of Breast Cancer in Shanghai, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy,
Abstract
The impact of renin-angiotensin-aldosterone system inhibitors on immune checkpoint inhibitor-associated adverse cardiovascular events.Org: National Taiwan University Hospital Yunlin Branch, Mount Auburn Hospital, Harvard Medical School, Cambridge University Hospitals NHS Foundation Trust, Taipei TzuChi Hospital,
Abstract
Prospective cardiovascular surveillance of immune checkpoint inhibitor-based combination therapy in patients with early-stage, triple-negative breast cancer.Org: University of Texas Southwestern Medical Center, UT Southwestern Medical Center,
Abstract
Treatment and treatment-related toxicity following subsequent breast cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, St. Jude Children's Research Hospital, University of Chicago Medicine, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Northwestern Medicine Lake Forest Hospital,
Abstract
Evaluation of cardiac failure and recovery in acute myelogenous leukemia.Org: University of Washington/Fred Hutchinson Cancer Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Hematology Division at University of Washington Medical Center, University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center/University of Washington,
Abstract
Clinical outcomes of patients with newly diagnosed acute myeloid leukemia receiving treatment in a safety-net hospital system.Org: Baylor College of Medicine, University of Texas MD Anderson Cancer Center,
Abstract
Predicting therapy-induced cardiomyopathy in long-term survivors of childhood cancer: A report from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor Study (CCSS).Org: St Jude Childrens Research Hospital, St. Jude Children's Research Hospital, University of Minnesota Masonic Cancer Center, Minneapolis, MN, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, University of Alabama at Birmingham Department of Hematology, Birmingham, AL,
Abstract
Taxane combined with lobaplatin or anthracycline for neoadjuvant treatment of triple-negative breast cancer: A single-center, randomized, controlled, phase-II clinical study.Org: Southwest Hospital Army Medical University, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Sounthwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Department of Thoracic Surgery, the Eighth Medical Center of Chinese PLA General Hospital, Chongqing, China, Central Medical Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. L., Nanjing, China,
Abstract
Use of PLR and NLR to evaluate the efficacy and prognosis of neoadjuvant chemotherapy with lobaplatin in triple-negative breast cancer.Org: Southwest Hospital Army Medical University, Army Medical University, Chongqing Precision Biotech, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Key Laboratory of Minimally Invasive Surgery and Precision Treatment for Breast Cancer of Chongqing Municipal Health Commission, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Sounthwest Hospital, Army Medical University, Chongqing, China, Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University; Department of Thoracic Surgery, the Eighth Medical Center of Chinese PLA General Hospital, Chongqing, China, Central Medical Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. L., Nanjing, China, 29 Gaotanyan Main Street,
Abstract
Association of anthracyclines induced cardiotoxicity (AIC) in patients with early breast cancer (eBC) with germline BRCA1/2 (gBRCA1/2) mutation: BRCAN study.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Ramón y Cajal University Hospital, Madrid, Spain, Cardiology Department, Biochemistry Department,
Abstract
Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A retrospective cohort study.Org: Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli–IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS - UOC Oncologia Medica, Roma, Italy, Università Cattolica del Sacro Cuore, Roma, Italy, Policlinico Gemelli, Roma, Italy, Fondazione Policlinico Gemelli, Rome, Roma, Italy, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, Precision medicine in senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, Fondazione Policlinico Gemelli, Rome, Rome, Italy, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy, Universita Cattolica Del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy, Italy,
Abstract
Efficacy and safety of anlotinib combined with anthracycline and ifosfamide followed by anlotinib maintenance in advanced soft tissue sarcoma: A single-arm, phase 2 trial.Org: Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Huaiyin District Jinan, China, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China, Shandong First Medical University and Shandong Academy of Medical Sciences, Huaiyin District Jinan, Jinan,
Abstract
Cardiac dysfunction (CD) among breast cancer survivors (BCS): Role of cardiotoxic therapy and cardiovascular risk factors.Org: University of Alabama at Birmingham School of Medicine, University of Alabama at Birmingham Department of Hematology, Birmingham, AL, University of Alabama School of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, Division of Hematology Oncology, UPMC Hillman Cancer Center/University of Pittsburgh,
Abstract
Congenital anomalies and health outcomes among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.Org: Baylor College of Medicine, Children's Hospital of Philadelphia, National Cancer Institute, Vilnius, Lithuania, Duke University Trent Center for Bioethics Humanities and History of Medicine, Durham, NC, University of Alabama at Birmingham School of Medicine,
Abstract
Prognostic value of systemic inflammatory response in early-stage triple-negative breast cancer.Org: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Institute of Oncology Ljubljana,
Abstract
Efficacy of paxman scalp cooling system at lower temperatures for prevention of anthracycline associated chemotherapy induced alopecia.Org: Memorial Sloan Kettering Cancer Center,
Abstract
Therapeutic strategies for metaplastic breast cancer: A clinicopathologic analysis of a single institution cohort.Org: University of California San Diego Medical Center, La Jolla, CA, UC San Diego Moores Cancer Center,
Abstract
Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan.Org: Mie University Graduate School of Medicine, Tsu, Japan, Shimane University Hospital, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Nagano Prefectural Shinshu Medical Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from Children’s Oncology Group and Childhood Cancer Survivor Study.Org: Department of Hematology & Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, University of North Texas, Denton, TX, St. Jude Children's Research Hospital, Memphis, TN, University of Alabama at Birmingham, Birmingham, AL, Northwestern University, Chicago, IL,
Abstract
Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience.Org: Memorial Sloan Kettering Cancer Center,
Abstract
Real-world, single-center experience on the outcomes of neoadjuvant chemotherapy and trastuzumab alone or in combination with pertuzumab in human epidermal growth factor receptor-2 breast cancer patients.Org: Medanta Medicity, Medanta - The Medicity, Medanta- The Medicity, Medanta-The Medicity, Medanta The Medicity,
Abstract
Pharmacological cardioprotective strategy for non-metastatic patients affected by breast cancer receiving an anthracycline-based chemotherapy: Final results of the phase 3 SAFE trial.Org: University of Florence, AOUC, Careggi University Hospital, Azienda Toscana Centro, ISPRO, Azienda Ospedaliera Universitaria Careggi,
Abstract
The impact of exercise training on the pathologic response and tumor immune microenvironment in breast cancer after neoadjuvant chemotherapy: An exploratory study.Org: Centro Hospitalar de Vila Nova de Gaia, Centro Hospitalar Vila Nova de Gaia/Espinho, Beira Interior University, Sport Sciences Department, Institute of Biomedicine of Seville,
Abstract
Characterization of patients with recurrent breast cancer submitted to neoadjuvant therapy in a Brazilian cancer center.Org: A.C. Camargo Cancer Center, Hospital ACCamargo, A.C. Camargo Hospital,
Abstract
Homologous recombination deficiency (HRD) status to predict the efficacy and prognosis of platinum-based neoadjuvant chemotherapy in patients with triple-negative breast cancer.Org: Fujian Medical University Union Hospital, Amoy Diagnostics Co., Ltd.,
Abstract
Efficacy comparison of anthracycline and taxane when added to immune checkpoint inhibitor in neoadjuvant chemotherapy of triple negative breast cancer: Clinical evidence from size-reduction measurement by ultrasound.Org: Chang Gung Memorial Hospital at Taipei, Chang Gung University Medical College, Chang Gung Memorial Hospital, Department of General Surgery, Chang Gung Memorial Hospital at Tao-Yuan, Tao-Yuan, Taiwan, Department of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL,
Abstract
Pathologic complete response in germline mutation carriers by mutation type and biomarkers in a safety-net population.Org: Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Baylor College of Medicine, Southern California Permanente Medical Group,
Abstract
De-escalating therapy dilemma in small HER2 positive node negative breast cancer.Org: Centre Oscar Lambret,
Abstract
Exosome-based delivery of microRNAs to confer adriamycin-resistance to sensitive cells through modulating the immune- and metabolism-related gene PTEN in HER2-negative breast cancer.Org: Department of General Surgery, Chang Gung Memorial Hospital at Tao-Yuan, Tao-Yuan, Taiwan, The First Affiliated Hospital with Nanjing Medical University,
Abstract
Clinicopathological features and treatment profile of patients referred to a sarcoma medical oncology centre in India: Challenges and insights from the developing world.Org: All India Institute of Medical Sciences, Delhi, India, All India Institute of Medical Sciences, New Delhi, India,
Abstract
Zanubrutinib plus obinutuzumab versus obinutuzumab in patients with relapsed/refractory follicular lymphoma: Updated analysis of the ROSEWOOD study.Org: Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy, Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital, Brno, Czech Republic, Institut Bergonié, Bordeaux, France, Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital, Barcelona, Spain, Peking University Cancer Hospital & Institute, Beijing, China,
Abstract
Treatment patterns and clinical outcomes of newly diagnosed early-stage and locally advanced triple negative breast cancer (TNBC): A retrospective cohort analysis of national real-world data in England.Org: Merck Sharp & Dohme, London Regional Cancer Center, Merck Sharpe & Dohme, Adelphi Real World, Bollington,
Abstract
Social determinants of health as a primary driver in outcomes in acute myeloid leukemia: An urban academic center experience.Org: VCU Massey Cancer Center, VCU School of Medicine, VCU Department of Internal Medicine, VCU Department of Biostatistics,
Abstract
Practice patterns in ongoing neoadjuvant ATNEC trial for patients with cT1-3N1M0 breast cancer: Response to neoadjuvant chemotherapy (NACT), targeted axillary dissection and breast conservation rates.Org: Royal Derby Hospital, University of Warwick, Royal Cornwall Hospitals NHS Trust, Aberdeen Royal Infirmary, NCRI Breast Clinical Studies Group,
Abstract
Pathologic complete response (pCR) to neoadjuvant treatment (NAT) with carboplatin, nab-paclitaxel and anthracycline in early and locally advanced triple-negative breast cancer (TNBC).Org: Medical Oncology Department, University Hospital Virgen del Rocío, Sevilla, Spain, Medical Oncology Department, University Hospital Puerto Real, Cádiz, Spain, Medical Oncology Department, University Hospital Virgen Macarena, Sevilla, Spain, University Hospital Virgen del Rocío, Sevilla, Spain, Hospital Virgen del Rocio de Sevilla. GEICAM Spanish Breast Cancer Group, Seville, Spain,
Abstract
Falls and hospitalization during chemotherapy in older women with early breast cancer.Org: City of Hope National Medical Center, Duarte, CA, University of Nebraska Medical Center, Omaha NE, Neurocentria,
Abstract
Knowledge gaps and educational needs for common cancer therapy-related cardiovascular toxicities and related drug interactions.Org: UNC Eshelman School of Pharmacy, Duke University Medical Center, Baptist Health Systems, North Memorial Hill Health, Baghdad Heart Center,
Abstract
Protective effect of the dexrazoxane against cardiotoxicity of the anthracycline in the treatment of the childhood cancers.Org: Ankara University, School of Medicine Department of Pedaitric Oncology, Department of Pediatric Cardiology, Ankara University Faculty of Medicine, Department of Pediatrics - Division of Pediatric Hematology-Oncology,
Abstract
Primary care utilization and cardiovascular screening in adult-aged survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Alberta, University of Washington and Fred Hutchinson Cancer Research Centre, St. Jude Children's Research Hospital,
Abstract
Anthracycline-related cardiotoxicity among patients with lymphoma: Systematic review and meta-analysis.Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic-Rochester, City of Hope National Medical Center,
Abstract
Cardiac iron overload in pediatric oncology and bone marrow transplant survivors.Org: Phoenix Children's Hospital - Center for Cancer and Blood Disorders, Phoenix Children's Hospital - Cardiology,
Abstract
Male breast cancer survival data and clinicopathological characteristics: A single-centre experience.Org: Hospital Agios Savvas, Agios Savvas Cancer Hospital, Saint Savvas Hospital, Agios Savvas Anticancer Hospital, Second Department of Medical Oncology,
Abstract
Multicenter real-world study of newly diagnosed advanced-stage extranodal natural killer/T-cell lymphoma (ENKTL): Proposal for intensive therapy.Org: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China, Beijing, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, WA, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China,
Abstract
Uterine sarcoma patients who underwent morcellation: Who are they? Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA- NOGGO RU1).Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Helios Klinikum Berlin-Buch, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Tuebingen University Hospital,
Abstract
A phase ll study on the neoadjuvant treatment of resectable high-risk soft tissue sarcoma with anlotinib and doxorubicin.Org: Henan Cancer Hospital, Zhengzhou Gensciences,
Product
AnthracyclinesAbstract
Real-world experience with liposomal doxorubicin in metastatic and locally advanced sarcoma.Org: Medical College of Wisconsin, Froedtert Hospital Cancer Center,
Abstract
Identification of predictive, treatment-specific Charlson comorbidity score thresholds in acute myeloid leukemia.Org: VCU Massey Cancer Center, VCU School of Medicine, VCU Department of Internal Medicine, VCU Department of Biostatistics,